Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Goldstick%2C+Lawrence%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Goldstick%2C+Lawrence%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Goldstick%2C+Lawrence%22&type=Person&sort=year
PubPharm (7)
1
Donanemab in Early Symptomatic Alzheimer Disease : The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
enthalten in:
JAMA
| 2023
von
Sims, J.
|
Zimmer, J.
|
Evans, C.
| +117
CommentIn: JAMA. 2023 Jul 17;:. - PMID 37459123
Wird geladen...
2
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA) : a randomised, controlled, open-label, phase 3b trial
enthalten in:
The Lancet. Neurology
| 2022
von
Foley, J.
|
Defer, G.
|
Ryerson, L.
| +98
CommentIn: Lancet Neurol. 2022 Jul;21(7):579-581. - PMID 35483388
Wird geladen...
3
Patient-Centered Treatment of Chronic Migraine With Medication Overuse : A Prospective, Randomized, Pragmatic Clinical Trial
enthalten in:
Neurology
| 2022
von
Schwedt, T.
|
Hentz, J.
|
Sahai-Srivastava, S.
| +36
CommentIn: Neurology. 2022 Apr 5;98(14):563-564. - PMID 35169016
Wird geladen...
4
Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids
enthalten in:
CNS neuroscience & therapeutics
| 2022
von
Wynn, D.
|
Goldstick, L.
|
Bauer, W.
| +5
Wird geladen...
5
Results from a multicenter, randomized, double‐blind, placebo‐controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids
enthalten in:
CNS Neuroscience & Therapeutics
| 2022
von
Wynn, D.
|
Goldstick, L.
|
Bauer, W.
| +5
Wird geladen...
6
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis : a phase 2b, randomised, double-blind, placebo-controlled trial
enthalten in:
The Lancet. Neurology
| 2021
von
Reich, D.
|
Arnold, D.
|
Vermersch, P.
| +54
CommentIn: Lancet Neurol. 2021 Sep;20(9):689-691. - PMID 34418385
Wird geladen...
7
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis
enthalten in:
Multiple sclerosis and related disorders
| 2014
von
Hughes, B.
|
Cascione, M.
|
Freedman, M.
| +10
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
7
Aufsätze
7
E-Artikel
7
E-Ressourcen
Zeitschriftentitel
2
The Lancet. Neurology
1
CNS Neuroscience & Therapeutics
1
CNS neuroscience & therapeutics
1
JAMA
1
Multiple sclerosis and related disorders
1
Neurology
Alle anzeigen ...
weniger ...
Thema
6
Journal Article
6
Research Support, Non-U.S. Gov't
5
Randomized Controlled Trial
3
Multicenter Study
1
9002-60-2
1
Acthar Gel
1
Adrenal Cortex Hormones
1
Adrenocorticotropic Hormone
1
Agammaglobulinaemia Tyrosine Kinase
1
Antibodies, Monoclonal
1
Clinical Trial, Phase II
1
Clinical Trial, Phase III
1
Clinical Trial, Phase IV
1
EC 2.7.10.2
1
Fingolimod
1
Fingolimod Hydrochloride
1
First-dose effects
1
G926EC510T
1
Immunosuppressive Agents
1
Multiple sclerosis
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
6
2020-
1
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6
Englisch
Haven't found what you're looking for?
Wird geladen...